Can-Fite BioPharma Ltd.

CANF | AMEX

Price Alert Chart Builder DCF Calculator

$2.22

-$0.02 (-0.89%)

At close: Sep 21, 2026, 4:00 PM ET

$2.26

+$0.04 (+1.74%)

Pre-market: Sep 22, 2026, 5:28 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-9.91M	-7.88M	-7.63M	-10.17M	-12.62M	-14.44M
Depreciation & Amortization	24.19K	7K	15K	14K	14K	12K
Stock-Based Compensation	n/a	362K	261K	263K	466K	355K
Other Working Capital	-110.87K	-458K	-474K	-1.24M	2.04M	-401K
Other Non-Cash Items	425.35K	141K	-139K	396K	-59K	1K
Deferred Income Tax	n/a	n/a	n/a	n/a	-94K	11K
Change in Working Capital	436.43K	-267K	-943K	-1.3M	2.43M	2M
Operating Cash Flow	-9.02M	-7.64M	-8.44M	-10.8M	-9.86M	-12.06M
Capital Expenditures	-2.02K	-5K	-2K	-9K	-11K	-26K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-14.5M	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	1.5M	500K	9.51M	n/a	n/a
Investing Cash Flow	-2.02K	1.5M	498K	9.5M	-14.51M	-26K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	9.72M	6.71M	9.14M	n/a	20.46M	17.68M
Net Cash Flow	702.92K	547K	1.3M	-1.41M	-3.88M	5.57M
Free Cash Flow	-9.02M	-7.64M	-8.44M	-10.81M	-9.87M	-12.09M
Adj. Free Cash Flow	-9.02M	-8M	-8.7M	-11.07M	-10.34M	-12.44M
Maintenance CapEx	-2.02K	-5K	-2K	-9K	-4.41K	-26K
Growth CapEx	n/a	n/a	n/a	n/a	-6.59K	n/a
Owner Earnings	-9.02M	-7.64M	-8.44M	-10.81M	-9.86M	-12.09M